158 related articles for article (PubMed ID: 34173819)
21. Measurement of endocrine disrupting and asthma-associated chemicals in hair products used by Black women.
Helm JS; Nishioka M; Brody JG; Rudel RA; Dodson RE
Environ Res; 2018 Aug; 165():448-458. PubMed ID: 29705122
[TBL] [Abstract][Full Text] [Related]
22. A prospective study of permanent hair dye use and hematopoietic cancer.
Grodstein F; Hennekens CH; Colditz GA; Hunter DJ; Stampfer MJ
J Natl Cancer Inst; 1994 Oct; 86(19):1466-70. PubMed ID: 8089866
[TBL] [Abstract][Full Text] [Related]
23. Hair dye use and risk of fatal cancers in U.S. women.
Thun MJ; Altekruse SF; Namboodiri MM; Calle EE; Myers DG; Heath CW
J Natl Cancer Inst; 1994 Feb; 86(3):210-5. PubMed ID: 8283493
[TBL] [Abstract][Full Text] [Related]
24. Type II diabetes mellitus and the incidence of epithelial ovarian cancer in the cancer prevention study-II nutrition cohort.
Gapstur SM; Patel AV; Diver WR; Hildebrand JS; Gaudet MM; Jacobs EJ; Campbell PT
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2000-5. PubMed ID: 22941335
[TBL] [Abstract][Full Text] [Related]
25. Early life exposure to tobacco smoke and ovarian cancer risk in adulthood.
Wang T; Townsend MK; Vinci C; Jake-Schoffman DE; Tworoger SS
Int J Epidemiol; 2021 Jul; 50(3):965-974. PubMed ID: 33647961
[TBL] [Abstract][Full Text] [Related]
26. Ovarian cancer and hormone replacement therapy in the Million Women Study.
Beral V; ; Bull D; Green J; Reeves G
Lancet; 2007 May; 369(9574):1703-10. PubMed ID: 17512855
[TBL] [Abstract][Full Text] [Related]
27. Sleep Characteristics and Risk of Ovarian Cancer Among Postmenopausal Women.
Liang X; Harris HR; Hendryx M; Shadyab AH; Hale L; Li Y; Crane TE; Cespedes Feliciano EM; Stefanick ML; Luo J
Cancer Prev Res (Phila); 2021 Jan; 14(1):55-64. PubMed ID: 32917642
[TBL] [Abstract][Full Text] [Related]
28. Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis.
Jordan SJ; Green AC; Whiteman DC; Moore SP; Bain CJ; Gertig DM; Webb PM; ;
Int J Cancer; 2008 Apr; 122(7):1598-603. PubMed ID: 18058817
[TBL] [Abstract][Full Text] [Related]
29. Maternal Exposure to Domestic Hair Cosmetics and Occupational Endocrine Disruptors Is Associated with a Higher Risk of Hypospadias in the Offspring.
Haraux E; Braun K; Buisson P; Stéphan-Blanchard E; Devauchelle C; Ricard J; Boudailliez B; Tourneux P; Gouron R; Chardon K
Int J Environ Res Public Health; 2016 Dec; 14(1):. PubMed ID: 28036072
[TBL] [Abstract][Full Text] [Related]
30. Perineal powder use and risk of ovarian cancer.
Houghton SC; Reeves KW; Hankinson SE; Crawford L; Lane D; Wactawski-Wende J; Thomson CA; Ockene JK; Sturgeon SR
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25214560
[TBL] [Abstract][Full Text] [Related]
31. Moderate-to-vigorous physical activity and leisure-time sitting in relation to ovarian cancer risk in a large prospective US cohort.
Hildebrand JS; Gapstur SM; Gaudet MM; Campbell PT; Patel AV
Cancer Causes Control; 2015 Nov; 26(11):1691-7. PubMed ID: 26335264
[TBL] [Abstract][Full Text] [Related]
32. Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.
Kotsopoulos J; Gronwald J; Karlan BY; Huzarski T; Tung N; Moller P; Armel S; Lynch HT; Senter L; Eisen A; Singer CF; Foulkes WD; Jacobson MR; Sun P; Lubinski J; Narod SA;
JAMA Oncol; 2018 Aug; 4(8):1059-1065. PubMed ID: 29710224
[TBL] [Abstract][Full Text] [Related]
33. Oral bisphosphonate use and the risk of female breast, ovarian, and cervical cancer: a nationwide population-based cohort study.
Bae YS; Chang J; Park SM
Arch Osteoporos; 2019 Mar; 14(1):41. PubMed ID: 30888545
[TBL] [Abstract][Full Text] [Related]
34. Depression and risk of epithelial ovarian cancer: Results from two large prospective cohort studies.
Huang T; Poole EM; Okereke OI; Kubzansky LD; Eliassen AH; Sood AK; Wang M; Tworoger SS
Gynecol Oncol; 2015 Dec; 139(3):481-6. PubMed ID: 26449316
[TBL] [Abstract][Full Text] [Related]
35. Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition.
Lahmann PH; Cust AE; Friedenreich CM; Schulz M; Lukanova A; Kaaks R; Lundin E; Tjønneland A; Halkjaer J; Severinsen MT; Overvad K; Fournier A; Chabbert-Buffet N; Clavel-Chapelon F; Dossus L; Pischon T; Boeing H; Trichopoulou A; Lagiou P; Naska A; Palli D; Grioni S; Mattiello A; Tumino R; Sacerdote C; Redondo ML; Jakszyn P; Sánchez MJ; Tormo MJ; Ardanaz E; Arriola L; Manjer J; Jirström K; Bueno-de-Mesquita HB; May AM; Peeters PH; Onland-Moret NC; Bingham S; Khaw KT; Allen NE; Spencer E; Rinaldi S; Slimani N; Chajes V; Michaud D; Norat T; Riboli E
Int J Cancer; 2010 May; 126(10):2404-15. PubMed ID: 19821492
[TBL] [Abstract][Full Text] [Related]
36. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Finch A; Beiner M; Lubinski J; Lynch HT; Moller P; Rosen B; Murphy J; Ghadirian P; Friedman E; Foulkes WD; Kim-Sing C; Wagner T; Tung N; Couch F; Stoppa-Lyonnet D; Ainsworth P; Daly M; Pasini B; Gershoni-Baruch R; Eng C; Olopade OI; McLennan J; Karlan B; Weitzel J; Sun P; Narod SA;
JAMA; 2006 Jul; 296(2):185-92. PubMed ID: 16835424
[TBL] [Abstract][Full Text] [Related]
37. Impact of hair relaxers in women in Nakuru, Kenya.
Etemesi BA
Int J Dermatol; 2007 Oct; 46 Suppl 1():23-5. PubMed ID: 17919201
[TBL] [Abstract][Full Text] [Related]
38. Associations of hair dye and relaxer use with breast tumor clinicopathologic features: Findings from the Women's circle of Health Study.
Rao R; McDonald JA; Barrett ES; Greenberg P; Teteh DK; Montgomery SB; Qin B; Lin Y; Hong CC; Ambrosone CB; Demissie K; Bandera EV; Llanos AAM
Environ Res; 2022 Jan; 203():111863. PubMed ID: 34390715
[TBL] [Abstract][Full Text] [Related]
39. A prospective cohort study of oral contraceptive use and ovarian cancer among women in the United States born from 1947 to 1964.
Shafrir AL; Schock H; Poole EM; Terry KL; Tamimi RM; Hankinson SE; Rosner BA; Tworoger SS
Cancer Causes Control; 2017 May; 28(5):371-383. PubMed ID: 28290016
[TBL] [Abstract][Full Text] [Related]
40. Lung cancer risk in relation to dietary acrylamide intake.
Hogervorst JG; Schouten LJ; Konings EJ; Goldbohm RA; van den Brandt PA
J Natl Cancer Inst; 2009 May; 101(9):651-62. PubMed ID: 19401552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
